Africa: WHO Endorses 'Historic' Malaria Vaccine for At-Risk Children
An infant surrounded by a protective mosquito net in Ghana.
6 OCTOBER 2021
UN News Service
The World Health Organization (WHO) is recommending widespread use of the world's first malaria vaccine, in what the UN health agency's chief described on Wednesday as "an historic day" for the decades-long battle against the deadly disease.
The vaccine is geared towards children, in sub-Saharan Africa and other regions with moderate to high transmission.
The recommendation to begin using the RTS,S vaccine, is based an ongoing pilot programme set up by WHO and partners in Ghana, Kenya and Malawi, that has reached more than 800,000 children since 2019.
"The long-awaited malaria vaccine for children is a breakthrough for science, child health and malaria control", said the WHO Director-General, Tedros Adhanom Ghebreyesus. "Using this vaccine on top of existing tools to prevent malaria could save tens of thousands of young lives each year."
Stagnation in progress
Tedros said the world had made "incredible progress" in the fight against malaria in the past two decades.
The malaria parasite is mostly transmitted by infective mosquitoes and carried in the blood, after being bitten. It is not contagious person-to-person, and symptoms include a fever of flu-like illness, nausea and vomiting, and if left untreated, it can be fatal, killing more than 400,000 each year worldwide.
Since 2000, deaths have fallen by more than half, and the disease has been eliminated in many parts of the world.
For the WHO chief, though, progress has stalled at an unacceptably high level, with more than 200 million cases still occurring each year. Two-thirds of those who die from the disease, are children under five in Africa.
Childhoods decimated
Malaria remains a primary cause of childhood illness and death in sub-Saharan Africa. More than 260,000 African children under the age of five die from malaria annually.
WHO Regional Director for Africa, Matshidiso Moeti, said that "for centuries, malaria has stalked sub-Saharan Africa, causing immense personal suffering."
"We have long hoped for an effective malaria vaccine and now for the first time ever, we have such a vaccine recommended for widespread use", she said.
For Ms. Moeti, today's recommendation "offers a glimmer of hope for the continent which shoulders the heaviest burden of the disease and we expect many more African children to be protected from malaria and grow into healthy adults."
Recommendations
Based on the advice of two WHO global advisory bodies, one for immunization and the other for malaria, the UN Agency has made a series of specific recommendations.
The immunization should be administered in regions with moderate to high transmission, in a schedule of four doses, in children from five months of age and up.
According to Tedros, the pilot study has shown that the vaccine can be easily delivered through child health clinics by Ministries of Health, reaching children with high coverage. There is strong community demand, and it has "broad reach to children, including the most vulnerable who may not use a bednet" to keep out mosquitoes, and it is highly cost-effective.
Deaths reduced by a third
To date, more than 2.3 million doses of the vaccine have been administered, showing a favorable safety profile.
The vaccine showed a significant reduction (30%) in deadly severe malaria, even when introduced in areas where insecticide-treated nets are widely used and there is good access to diagnosis and treatment.
The study showed that the distribution of the vaccine had no negative impact on uptake of bednets, other childhood vaccinations, or health-seeking behavior for other febrile illness.
The next steps will include funding decisions from the global health community for broader rollout, and country decision-making on whether to adopt the vaccine as part of national malaria control strategies.
"This is a powerful new tool, but like COVID-19 vaccines, it's not the only tool", stressed Tedros. Vaccination against malaria does not replace or reduce the need for other measures, including bednets, or seeking care for fever."
Read the original article on UN News.
Thank you for reaching out to us. We are happy to receive your opinion and request. If you need advert or sponsored post, We’re excited you’re considering advertising or sponsoring a post on our blog. Your support is what keeps us going. With the current trend, it’s very obvious content marketing is the way to go. Banner advertising and trying to get customers through Google Adwords may get you customers but it has been proven beyond doubt that Content Marketing has more lasting benefits.
We offer majorly two types of advertising:
1. Sponsored Posts: If you are really interested in publishing a sponsored post or a press release, video content, advertorial or any other kind of sponsored post, then you are at the right place.
WHAT KIND OF SPONSORED POSTS DO WE ACCEPT?
Generally, a sponsored post can be any of the following:
Press release
Advertorial
Video content
Article
Interview
This kind of post is usually written to promote you or your business. However, we do prefer posts that naturally flow with the site’s general content. This means we can also promote artists, songs, cosmetic products and things that you love of all products or services.
DURATION & BONUSES
Every sponsored article will remain live on the site as long as this website exists. The duration is indefinite! Again, we will share your post on our social media channels and our email subscribers too will get to read your article. You’re exposing your article to our: Twitter followers, Facebook fans and other social networks.
We will also try as much as possible to optimize your post for search engines as well.
Submission of Materials : Sponsored post should be well written in English language and all materials must be delivered via electronic medium. All sponsored posts must be delivered via electronic version, either on disk or e-mail on Microsoft Word unless otherwise noted.
PRICING
The price largely depends on if you’re writing the content or we’re to do that. But if your are writing the content, it is $100 per article.
2. Banner Advertising: We also offer banner advertising in various sizes and of course, our prices are flexible. you may choose to for the weekly rate or simply buy your desired number of impressions.
Technical Details And Pricing
Banner Size 300 X 250 pixels : Appears on the home page and below all pages on the site.
Banner Size 728 X 90 pixels: Appears on the top right Corner of the homepage and all pages on the site.
Large rectangle Banner Size (336x280) : Appears on the home page and below all pages on the site.
Small square (200x200) : Appears on the right side of the home page and all pages on the site.
Half page (300x600) : Appears on the right side of the home page and all pages on the site.
Portrait (300x1050) : Appears on the right side of the home page and all pages on the site.
Billboard (970x250) : Appears on the home page.
Submission of Materials : Banner ads can be in jpeg, jpg and gif format. All materials must be deliverd via electronic medium. All ads must be delivered via electronic version, either on disk or e-mail in the ordered pixel dimensions unless otherwise noted.
For advertising offers, send an email with your name,company, website, country and advert or sponsored post you want to appear on our website to advert @ alexa. ng
Normally, we should respond within 48 hours.